COST TO SOCIETY DUE TO UNDEREMPLOYMENT IN PERSONS WITH HEMOPHILIA A AND B - HEMOPHILIA UTILIZATION GROUP STUDY V (HUGS V)

被引:0
|
作者
Niu, X. [1 ]
Poon, J. L. [1 ]
Riske, B. [2 ]
Baker, J. [3 ]
Ullman, M. [4 ]
Gwadry-Sridhar, F. [5 ]
Lou, M. [6 ]
Nichol, M. B. [1 ]
机构
[1] Univ So Calif, Los Angeles, CA USA
[2] Univ Colorado Denver, Aurora, CO USA
[3] Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA USA
[4] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA
[5] Univ Western Ontario, London, ON, Canada
[6] USC Sch Pharm, Los Angeles, CA USA
关键词
D O I
10.1016/j.jval.2013.03.574
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A119 / A120
页数:2
相关论文
共 50 条
  • [41] Presence of Factor V Leiden or Prothrombin Mutation Influence Inhibitor Development in Children with Severe Hemophilia A: Data of a Multicenter Cohort Study
    Kurnik, Karin
    Bidlingmaier, Christoph
    During, Christine
    Halimeh, Susan
    Schobess, Rosemarie
    Nowak-Gottl, Ulrike
    [J]. BLOOD, 2008, 112 (11) : 96 - 96
  • [42] Cost of on-demand treatment of severe hemophilia A and B with high responding inhibitor: A 2-year retrospective study.
    Laurian, Y
    Schmit, B
    dOiron, R
    Rafowicz, A
    Lambert, T
    [J]. BLOOD, 1997, 90 (10) : 151 - 151
  • [43] Concizumab prophylaxis in persons with hemophilia A or B with inhibitors: patient-reported outcome results from the phase 3 explorer7 study
    Tran, Huyen
    von Mackensen, Sylvia
    Abraham, Aby
    Castaman, Giancarlo
    Hampton, Kingsley
    Knoebl, Paul
    Linari, Silvia
    Odgaard-Jensen, Jan
    Neergaard, Jesper Skov
    Stasyshyn, Oleksandra
    Zaw, Jay Jay Thaung
    Zulfikar, Bulent
    Shapiro, Amy
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (04)
  • [44] Adherence to prophylaxis treatment regimens among persons with severe hemophilia A and B: Results from a one-year, single-institution study
    Khleif, A.
    Gustafson, S.
    Rodriguez, N.
    Nguyen, T.
    Brown, D.
    Escobar, M.
    [J]. HAEMOPHILIA, 2012, 18 : 162 - 163
  • [45] Known-group validity of patient-reported outcome (PRO) instruments and hemophilia joint health score v2.1 (HJHS) in US adult people with hemophilia (PWH): results from the pain, functional impairment, and quality of life (P-FiQ) study
    Buckner, T. W.
    Wang, M.
    Cooper, D. L.
    Kempton, C.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 48 - 49
  • [46] Safety and efficacy of coagulation Factor VIIa (recombinant) when administered as i.v. bolus or i.v. continuous infusion to hemophilia A or B patients with inhibitors undergoing elective major surgical procedures
    Gilchrist, GS
    Green, D
    Hoots, K
    Konkle, BA
    Erhardtsen, E
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 97 - 98
  • [47] A relativistic density functional study of early transition metal group III B V B dimers
    Lu, X
    Liao, MS
    Xu, X
    Wang, NQ
    Zhang, QE
    [J]. CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 1996, 12 (02) : 175 - 183
  • [48] Incidence of inhibitors in previously untreated hemophilia patients - Preliminary results of a prospective multicenter study of the pediatric working group to the GTH (German Society of Thrombosis and Hemostasis Research)
    Klose, HJ
    Auerswald, G
    EscuriolaEttingshausen, C
    Kreuz, W
    Lenk, H
    MartinezSaguer, I
    Budde, U
    [J]. BLOOD, 1996, 88 (10) : 3031 - 3031
  • [49] Impact of Blood Transfusion on the Prevalence of HHpgV-1, HPgV-1, and B19V Among Iranian HCV-infected Patients With Hemophilia
    Agi, Elnaz
    Hojjatipour, Samira
    Namvar, Ali
    Bolhassani, Azam
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (04) : E213 - E218
  • [50] Internal consistency and item-total correlation of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adult people with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study
    Wang, Michael
    Batt, Katharine
    Kessler, Craig
    Neff, Anne
    Iyer, Neeraj N.
    Cooper, David L.
    Kempton, Christine L.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1831 - 1839